Amrubicin Chemotherapy as First Line in Metastatic or Unresectable Soft Tissue Sarcoma

NCT01259375 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
24
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University of Utah